Connect with us

Business

Eli Lilly hikes price of diabetes drug Mounjaro in UK as Trump pressures pharma to align drug costs

Published

on

Eli Lilly hikes price of diabetes drug Mounjaro in UK as Trump pressures pharma to align drug costs


Mounjaro manufactured by Eli Lilly and Company packaging is seen in this illustration photo taken in a pharmacy in Krakow, Poland on April 9, 2024.

Nurphoto | Nurphoto | Getty Images

Eli Lilly on Thursday said it is raising the list price of its blockbuster diabetes drug Mounjaro in the U.K. starting in September, as President Donald Trump pressures drugmakers to lower U.S. drug prices and hike them abroad.

In a statement, Eli Lilly said it reached an agreement with the U.K. government to increase the list price of the weekly injection, while “maintaining access” for patients covered under the publicly funded health-care system, the National Health Service, or NHS. 

Eli Lilly told CNBC that the price hike will not affect the drug’s availability under NHS, and it wants to work with the government to boost access. The company added that it does not determine prices that private health-care providers set, but is working with them to ensure access to Mounjaro. 

In a statement on Thursday, NHS said Mounjaro’s list price increase “will not affect NHS commissioning of tirzepatide in England for eligible people living with obesity, based on clinical priority, or as a treatment for type 2 diabetes.” Tirzepatide is the active ingredient in Mounjaro and its counterpart for weight loss, Zepbound.

Mounjaro’s current list price in the UK ranges from £92 (about $124.89) to £122 a month, depending on the dose size, according to Eli Lilly. The drug’s new list price will increase to between £133 and £330 starting on Sept. 1. 

The company added that it is working with certain governments and expects to make pricing adjustments in those countries by that date. In the U.S., the list price for a month’s supply of Mounjaro is $1,079.77 before insurance and other rebates. 

Eli Lilly said it supports the Trump administration’s goal of keeping the U.S. the “world’s leading destination for biopharmaceutical research and manufacturing, and the objective of more fairly sharing the costs of breakthrough medical research across developed countries.” 

“This rebalancing may be difficult, but it means the prices for medicines paid by governments and health systems need to increase in other developed markets like Europe in order to make them lower in the US,” the company said in the statement.

The announcement comes after Trump in July sent separate letters to 17 drugmakers, including Eli Lilly, calling on them to take steps to lower drug prices by Sept. 29. The move built on the president’s executive order in May reviving a controversial plan – the “most favored nation” policy – that aims to slash drug costs by tying the prices of some medicines in the U.S. to the significantly lower ones abroad.

U.S. prescription drug prices are two-to-three times higher on average than those in other developed nations – and up to 10 times more than in certain countries, according to the Rand Corp., a public policy think tank. Trump has said he wants to narrow that gap to stop Americans from being “ripped off.”

Eli Lilly’s announcement on Thursday comes as the industry braces for Trump’s planned tariffs on pharmaceuticals imported into the U.S. In its statement, the company said it opposes those tariffs, arguing they will “raise costs, limit patient access, and undermine American leadership, especially for companies already investing heavily in domestic manufacturing.”

In recent months, Eli Lilly was among several drugmakers to announce new plans to invest in U.S. manufacturing sites.



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Two ships hit near Strait of Hormuz as fears grow of oil price rises

Published

on

Two ships hit near Strait of Hormuz as fears grow of oil price rises



International shipping is said to have come to a standstill at the strait’s entrance, with fears of disruption already pushing up global oil prices.



Source link

Continue Reading

Business

Khamenei dead, Middle East on edge: What will be the implications of Trump’s ‘Epic fury’ on stock markets, gold & oil? – The Times of India

Published

on

Khamenei dead, Middle East on edge: What will be the implications of Trump’s ‘Epic fury’ on stock markets, gold & oil? – The Times of India


Experience shows markets often come to view geopolitical disruptions as temporary. (AI image)

The global markets are in for a phase of enhanced turmoil and uncertainty! The ongoing tensions in the Middle East after US and Israel’s strikes on Iran and Ali Khamenei’s death may have investors running for cover – looking for an asset class that is safer.During the night of February 27–28, the United States and Israel carried out joint aerial strikes on Iran as part of “Operation Epic Fury.” Statements by President Trump openly referring to regime change suggest that the confrontation could evolve into a prolonged campaign rather than remain a limited exchange, say market analysts at Franklin Templeton Institute.What does the situation mean for stock markets, energy markets (oil), gold and other asset classes? Here’s what Franklin Templeton Institute analysts have to say:From a market perspective, the key uncertainty is whether the conflict remains confined to direct military engagement or expands into disruptions affecting energy supplies and logistics networks, which would sustain a higher and more persistent risk premium.At the centre of the ongoing uncertainty from a global market and trade perspective is the Strait of Hormuz. While a complete blockade would carry severe consequences for Iran itself, the country has the capability to disrupt maritime traffic through tactics such as vessel harassment, seizures, drone activity, cyber operations, or the use of proxy forces.

Strait of Hormuz

Strait of Hormuz

The most immediate economic impact is expected in energy markets, where crude oil and natural gas prices are likely to move higher, they say. Such actions, feel analysts, will keep geopolitical risk premiums at high levels. In 2024, approximately 20 million barrels per day moved through the Strait of Hormuz, which is around one-fifth of global petroleum liquids consumption. Even a limited interference – which can be caused by delays, rerouting, or isolated seizure – can push prices higher through increased risk perception well before any actual shortages emerge.Liquefied natural gas should not be overlooked in this context. Qatar has the world’s third-largest LNG export capacity, and roughly one-fifth of global LNG shipments pass through the Strait of Hormuz, largely consisting of Qatari exports. As a result, shipping risks in the region affect gas markets as significantly as oil markets.Also Read | US-Israel strikes on Iran: How will India be hit by Strait of Hormuz closure? ExplainedShipping expenses have already begun to rise, with insurance costs acting as a major driver. Insurers have started issuing cancellation notices and revising war-risk premiums for voyages in the Gulf region. Some routes have reportedly seen premium increases of up to about 50%, while earlier periods of tension recorded rises exceeding 60% on important trade corridors. These developments effectively tighten supply conditions even when production levels remain unchanged.The possibility of the conflict spreading across the region is increasing. Franklin Templeton Institute analysts are of the view that across global financial markets, the immediate response to such shocks is usually driven by adjustments in risk perception rather than by underlying economic changes. “The initial market reaction for this type of event would typically see Treasury yields move lower and equities lower—mostly a risk-premium repricing. Impacts on activity/earnings may be delayed and uneven. The US dollar reaction is not guaranteed; gold tends to benefit while bitcoin has been trading like a risk asset (i.e., down with equities), reinforcing that it’s not typically a reliable hedge/diversifier in geopolitical drawdowns,” say Franklin Templeton Institute analysts.However, they note that experience shows markets often come to view geopolitical disruptions as temporary. Initial spikes in risk premiums are frequently followed by the realization that the overall effect on corporate profitability is limited. The duration of the conflict, developments in shipping and insurance costs, and the eventual resolution will be more important than the initial headlines.“We would not yet label this a clean buy-the-dip setup—duration, shipping/insurance mechanics, and the endgame matter more than the first headline,” they say.From an investment perspective, the near-term outlook favours sectors linked to energy markets, as well as companies benefiting from higher shipping and insurance costs, along with defence-related industries, the analysts say. At the same time, caution is warranted toward emerging markets that depend heavily on energy imports and toward cyclical sectors sensitive to fuel and logistics costs, including airlines and certain industrial segments.“For protection, we prefer oil upside/volatility structures and selective gold exposure over broad equity shorts—the path will be driven more by shipping/insurance reality than by the new cycle,” they conclude.



Source link

Continue Reading

Business

Crude oil prices in focus: OPEC+ increases output by 206,000 bpd amid Middle East tensions – The Times of India

Published

on

Crude oil prices in focus: OPEC+ increases output by 206,000 bpd amid Middle East tensions – The Times of India


OPEC+ on Sunday announced a higher-than-expected increase in oil production quotas, days after US and Israeli strikes on Tehran triggered Iranian retaliation across the Middle East, according to AFP.The oil producers’ group, which includes Saudi Arabia, Russia and several Gulf states affected by the escalation, said it had “agreed on a production adjustment of 206 thousand barrels per day”.“This adjustment will be implemented in April,” OPEC+ said in a statement.While the cartel did not directly refer to the Iran conflict, it cited “a steady global economic outlook and current healthy market fundamentals” as the rationale behind the output increase.The move comes amid heightened geopolitical tensions in the Middle East, a region critical to global crude oil supply.

-

The announcement did not directly reference the outbreak of the Iran conflict, instead attributing the decision to “a steady global economic outlook and current healthy market fundamentals”.Before the meeting, analysts had projected a more modest increase of 137,000 barrels per day.However, Jorge Leon, an analyst at Rystad Energy, cautioned that the agreed hike may not be sufficient to offset the potential impact of escalating tensions on crude oil markets.Leon highlighted the risk of disruption in the Strait of Hormuz, a critical waterway through which nearly a quarter of the world’s seaborne oil supplies transit.Iran’s Revolutionary Guards have reportedly contacted vessels to declare the strait closed. Iranian state television on Sunday said an oil tanker attempting to “illegally” pass through the strait was struck and was sinking, broadcasting footage of a burning tanker at sea.“If oil cannot move through Hormuz, an extra 206,000 barrels per day does very little to ease the market,” Leon said, adding that “logistics and transit risk matter more than production targets right now”.He said the OPEC+ move “is unlikely to calm markets”, noting that “prices will respond to developments in the Gulf and the status of shipping flows, not to a relatively small increase in output.”Apart from Russia and Saudi Arabia, the V8 group includes Kuwait, Oman, Iraq and the United Arab Emirates — all of which were targeted by Iranian attacks for a second consecutive day on Sunday. Algeria and Kazakhstan are also part of the group.



Source link

Continue Reading

Trending